News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features US Chest Pain Guidelines Will Change Practice, Though Gaps Remain Yael L. Maxwell December 06, 2021
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes Michael O'Riordan May 12, 2020
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017